Advanced CKD: Rivaroxaban Adds Bleeding, Not Benefit
TRACK found that low-dose rivaroxaban failed to reduce cardiovascular events while increasing major bleeding in advanced CKD, arguing against routine preventive use.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.